The FDA has banned products from a Chinese API maker and suggested it get a consultant to direct upgrades after an inspection found serious problems in its manufacturing processes, some of which had ...
The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent to Spanish active pharmaceutical ingredient (API) maker Interquim, S.A. for several good manufacturing practices ...
The FDA, disappointed in the manufacturing methods it saw at a Chinese API maker’s facility during a fall inspection, first put Sichuan Friendly Pharmaceutical on its import alert list and has now ...
The US Food and Drug Administration (FDA) on Monday released a warning letter sent to active pharmaceutical ingredient (API) maker Qinhuangdao Zizhu Pharmaceutical for data integrity issues uncovered ...
The contract research and manufacturing firm Albany Molecular Research Inc. has acquired Gadea Pharmaceutical, a Spanish maker of active pharmaceutical ingredients (APIs) and finished drugs, for $174 ...
Human API, maker of a consumer-facing health data sharing platform, announced last week the close of "over $20 million" in Series C funding. The raise saw backers Samsung Ventures, CNO Financial Group ...
The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More On average, it costs $20,000 USD to build an application programming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results